Pharmabiz46m
QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
Pharmabiz1h
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems
Silicon Labs unveils BG29 positioned as future of Bluetooth LE in miniature devices ideal for connected health systems: Our Bureau, Bengaluru Thursday, March 13, 2025, 14:30 Hrs [ ...
Pharmabiz1h
SunAct Cancer Institute partners with Smita Memorial Hospital and India’s oncology pioneer Dr Suresh Advani to redefine cancer treatment
Our Bureau, Mumbai Thursday, March 13, 2025, 14:15 Hrs [IST] ...
Pharmabiz1h
SK bioscience begins shipping of its self-developed influenza vaccine, SKYCellflu to Southern Hemisphere market
SK bioscience begins shipping of its self-developed influenza vaccine, SKYCellflu to Southern Hemisphere market: Seongnam, South Korea Thursday, March 13, 2025, 14:00 Hrs [IST] SK ...
Pharmabiz2h
Encube R&D centre for the life sciences industry opens at Palava
Encube R&D centre for the life sciences industry opens at Palava: Our Bureau, Mumbai Thursday, March 13, 2025, 13:45 Hrs [IST] Encube Ethicals has officially opened its flagship r ...
Pharmabiz2h
Halia Therapeutics awarded Novo Nordisk Golden Ticket to advance obesity and inflammation research
Halia Therapeutics awarded Novo Nordisk Golden Ticket to advance obesity and inflammation research: Lehi, Utah Thursday, March 13, 2025, 13:00 Hrs [IST] Halia Therapeutics, a clin ...
Pharmabiz23h
Aakash Healthcare in association with ANVKA Foundation launches nationwide initiative to transform lives of children with bone deformities
Our Bureau, Mumbai Wednesday, March 12, 2025, 16:45 Hrs [IST] ...
Pharmabiz4h
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...
Pharmabiz7h
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items
DGFT seeks industry feedback on proposed amendments to "stock and sale" export authorization for SCOMET items: Shardul Nautiyal, Mumbai Thursday, March 13, 2025, 08:00 Hrs [IST] T ...
Pharmabiz5h
Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients
Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...
Pharmabiz7h
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology
ICMR boosts aviation medicine with its new Centre for Advanced Research on Space Psychology: Nandita Vijayasimha Bengaluru Thursday, March 13, 2025, 08:00 Hrs [IST] The Indian Cou ...
Pharmabiz7h
Panel raises concern over regulatory roadblocks affecting medical devices sector
Panel raises concern over regulatory roadblocks affecting medical devices sector: Gireesh Babu, New Delhi Thursday, March 13, 2025, 08:00 Hrs [IST] The delays and lack of transpar ...